\-\ Texto\\:\\ \ \(0\)\
\-\ abd\\:\\ obese\\,\\ soft\\,\\ ttp\\ suprapubic\\ area\\,\\ nd\\,\\ bs\\ present\\,\\ no\\ peritoneal\\ signs\ \(0\)\
\-\ skin\\:\\ 4cm\\ r\\ groin\\ hematoma\\,\\ several\\ areas\\ of\\ resolving\\ hematomas\\ on\\ abdomen\\,\\ large\\ hematoma\\ on\\ l\\ flank\ \(0\)\
\-\ h\\/h\\:\\ initially\\ 13\\/38\\,\\ pod\\#1\\ 7\\.8\\/22\\.7\ \(0\)\
\-\ pod\\#2\\ ct\\ cystogram\\ \\(not\\ shown\\)\\ showed\\ the\\ fluid\\ collection\\ increased\\ to\\ 16cm\\ x\\ 16cm\\ x\\ 18cm\\,\\ with\\ no\\ contrast\\ extravasation\\ from\\ the\\ bladder\\.\\ h\\/h\\ continued\\ to\\ drop\\,\\ taken\\ to\\ or\\ where\\ a\\ defect\\ in\\ the\\ r\\ femoral\\ vein\\ was\\ repaired\\.\\ post\\-op\\,\\ bp\\ responded\\ to\\ ivf\\ and\\ blood\\ transfusions\ \(0\)\
\-\ fluid\\ seen\\ around\\ r\\ common\\ femoral\\ vein\\ and\\ artery\\ that\\ is\\ moving\\ posterior\\ to\\ rectus\\ abdominis\\ muscles\\,\\ ending\\ in\\ a\\ large\\ fluid\\ collection\\ anterior\\ to\\ the\\ bladder\\.\\ \\ well\\-circumscribed\\ 10\\.5cm\\ x\\ 7\\.5cm\\ x\\ 9\\.5cm\\ fluid\\ collection\\ within\\ the\\ space\\ of\\ retzius\ \(0\)\
\-\ extravasation\\ of\\ blood\\ from\\ r\\ common\\ femoral\\ artery\\ and\\ vein\\.\ \(0\)\
\-\ hematoma\\,\\ urine\\,\\ abscess\ \(0\)\
\-\ 58yo\\ f\\,\\ pmh\\ significant\\ for\\ dvtx3\\ on\\ coumadin\\ therapy\\ at\\ home\\,\\ currently\\ on\\ lovenox\\ window\\,\\ pod\\ \\#1\\ s\\/p\\ normal\\ cardiac\\ catheterization\\,\\ continued\\ hypotension\\ s\\/p\\ cath\\,\\ had\\ an\\ episode\\ of\\ lightheadedness\\ with\\ fall\\.\ \(0\)\
\-\ bleeding\\ s\\/p\\ cardiac\\ catheterization\\ has\\ been\\ reported\\ in\\ the\\ range\\ of\\ 2\\-14\\%\\,\\ retroperitoneal\\ bleeding\\ reported\\ in\\ 0\\.12\\-0\\.3\\%\\ of\\ cases\\.\\ risk\\ factors\\ for\\ vascular\\ complications\\ s\\/p\\ cath\\ include\\ age\\>70\\,\\ female\\,\\ bsa\\ \\<1\\.6\\,\\ chf\\,\\ copd\\,\\ le\\ vascular\\ disease\\,\\ mi\\,\\ bleeding\\ disorder\\,\\ shock\\,\\ and\\ plavix\\ use\\.\\ \\ furthermore\\,\\ enoxaparin\\ given\\ on\\ the\\ day\\ of\\ the\\ cath\\ doubled\\ the\\ patient\\â\\€\\™s\\ risk\\ of\\ bleeding\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cath\\:\\ 0\\.07720800548070426\ \(0\)\
\-\ pod\\:\\ 0\\.07525456022934046\ \(0\)\
\-\ 16cm\\:\\ 0\\.06296798874261784\ \(0\)\
\-\ r\\:\\ 0\\.055443492726225806\ \(0\)\
\-\ bleeding\\:\\ 0\\.05299389928665597\ \(0\)\
\-\ s\\/p\\:\\ 0\\.05120585438731302\ \(0\)\
\-\ h\\/h\\:\\ 0\\.04273075057078773\ \(0\)\
\-\ x\\:\\ 0\\.04027237621924967\ \(0\)\
\-\ catheterization\\:\\ 0\\.0391665279556521\ \(0\)\
\-\ collection\\:\\ 0\\.03875380063607864\ \(0\)\
\-\ extravasation\\:\\ 0\\.03757264544626489\ \(0\)\
\-\ \\#\\:\\ 0\\.03591092806008095\ \(0\)\
\-\ femoral\\:\\ 0\\.03483212160689791\ \(0\)\
\-\ fluid\\:\\ 0\\.034694844351483616\ \(0\)\
\-\ vein\\:\\ 0\\.033127857021579825\ \(0\)\
\-\ hematoma\\:\\ 0\\.03258178798309382\ \(0\)\
\-\ 13\\/38\\:\\ 0\\.03148399437130892\ \(0\)\
\-\ 7\\.8\\/22\\.7\\:\\ 0\\.03148399437130892\ \(0\)\
\-\ dvtx3\\:\\ 0\\.03148399437130892\ \(0\)\
\-\ 2\\-14\\:\\ 0\\.03148399437130892\ \(0\)\
\-\ 0\\.12\\-0\\.3\\:\\ 0\\.03148399437130892\ \(0\)\
\-\ 18cm\\:\\ 0\\.029008468726451974\ \(0\)\
\-\ 10\\.5cm\\:\\ 0\\.029008468726451974\ \(0\)\
\-\ 7\\.5cm\\:\\ 0\\.029008468726451974\ \(0\)\
\-\ retzius\\:\\ 0\\.029008468726451974\ \(0\)\
\-\ bsa\\:\\ 0\\.029008468726451974\ \(0\)\
\-\ \\,\\:\\ 0\\.029004649876852216\ \(0\)\
\-\ 58yo\\:\\ 0\\.0275603790546371\ \(0\)\
\-\ enoxaparin\\:\\ 0\\.0275603790546371\ \(0\)\
\-\ 9\\.5cm\\:\\ 0\\.026532943081595026\ \(0\)\
\-\ lightheadedness\\:\\ 0\\.026532943081595026\ \(0\)\
\-\ doubled\\:\\ 0\\.026532943081595026\ \(0\)\
\-\ continued\\:\\ 0\\.02628371419225883\ \(0\)\
\-\ bladder\\:\\ 0\\.024774363523207353\ \(0\)\
\-\ cystogram\\:\\ 0\\.024534315267539946\ \(0\)\
\-\ abdominis\\:\\ 0\\.024534315267539946\ \(0\)\
\-\ nd\\:\\ 0\\.023260476182044472\ \(0\)\
\-\ mi\\:\\ 0\\.023260476182044472\ \(0\)\
\-\ cardiac\\:\\ 0\\.02324883423536407\ \(0\)\
\-\ plavix\\:\\ 0\\.02292008268274331\ \(0\)\
\-\ suprapubic\\:\\ 0\\.022609327764923203\ \(0\)\
\-\ ivf\\:\\ 0\\.022609327764923203\ \(0\)\
\-\ responded\\:\\ 0\\.02232346095180343\ \(0\)\
\-\ lovenox\\:\\ 0\\.02232346095180343\ \(0\)\
\-\ reported\\:\\ 0\\.022250534646970084\ \(0\)\
\-\ risk\\:\\ 0\\.02210861890970776\ \(0\)\
\-\ transfusions\\:\\ 0\\.021161238093108336\ \(0\)\
\-\ ending\\:\\ 0\\.02096814087428592\ \(0\)\
\-\ shock\\:\\ 0\\.02028580074299053\ \(0\)\
\-\ vascular\\:\\ 0\\.02001288048516926\ \(0\)\
\-\ 4cm\\:\\ 0\\.01971314842129346\ \(0\)\
\-\ coumadin\\:\\ 0\\.01933686086537265\ \(0\)\
\-\ le\\:\\ 0\\.01933686086537265\ \(0\)\
\-\ bs\\:\\ 0\\.019219754355290542\ \(0\)\
\-\ hematomas\\:\\ 0\\.019219754355290542\ \(0\)\
\-\ resolving\\:\\ 0\\.019106366147024184\ \(0\)\
\-\ 1\\.6\\:\\ 0\\.019106366147024184\ \(0\)\
\-\ chf\\:\\ 0\\.019106366147024184\ \(0\)\
\-\ repaired\\:\\ 0\\.018996467366071492\ \(0\)\
\-\ drop\\:\\ 0\\.018786322723132444\ \(0\)\
\-\ moving\\:\\ 0\\.018685712448251388\ \(0\)\
\-\ hypotension\\:\\ 0\\.018685712448251388\ \(0\)\
\-\ furthermore\\:\\ 0\\.018685712448251388\ \(0\)\
\-\ copd\\:\\ 0\\.018309424892330575\ \(0\)\
\-\ artery\\:\\ 0\\.018175214229344278\ \(0\)\
\-\ post\\-op\\:\\ 0\\.017888771193557782\ \(0\)\
\-\ groin\\:\\ 0\\.017733467222344427\ \(0\)\
\-\ obese\\:\\ 0\\.017658276475209313\ \(0\)\
\-\ rectus\\:\\ 0\\.017658276475209313\ \(0\)\
\-\ window\\:\\ 0\\.017658276475209313\ \(0\)\
\-\ ttp\\:\\ 0\\.01730438039433706\ \(0\)\
\-\ blood\\:\\ 0\\.016660079089352138\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.01626013766758994\ \(0\)\
\-\ abd\\:\\ 0\\.016160924938636096\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.016160924938636096\ \(0\)\
\-\ common\\:\\ 0\\.015973337228259978\ \(0\)\
\-\ f\\:\\ 0\\.015924319990274667\ \(0\)\
\-\ peritoneal\\:\\ 0\\.01587882346964099\ \(0\)\
\-\ pmh\\:\\ 0\\.015182750830352365\ \(0\)\
\-\ episode\\:\\ 0\\.015109110518914021\ \(0\)\
\-\ urine\\:\\ 0\\.014729180506204838\ \(0\)\
\-\ 70\\:\\ 0\\.014664243652336302\ \(0\)\
\-\ 1\\:\\ 0\\.014523759771140763\ \(0\)\
\-\ home\\:\\ 0\\.014506886545929049\ \(0\)\
\-\ flank\\:\\ 0\\.014356170994177703\ \(0\)\
\-\ \\%\\:\\ 0\\.014238007381042911\ \(0\)\
\-\ muscles\\:\\ 0\\.013938798350823022\ \(0\)\
\-\ l\\:\\ 0\\.013912633921922761\ \(0\)\
\-\ factors\\:\\ 0\\.013709945291235441\ \(0\)\
\-\ disorder\\:\\ 0\\.013709945291235441\ \(0\)\
\-\ fall\\:\\ 0\\.013425973637922107\ \(0\)\
\-\ large\\:\\ 0\\.013346731655936283\ \(0\)\
\-\ bp\\:\\ 0\\.013248474821663992\ \(0\)\
\-\ on\\:\\ 0\\.012926625220811215\ \(0\)\
\-\ taken\\:\\ 0\\.012725874985428102\ \(0\)\
\-\ around\\:\\ 0\\.012707225185495417\ \(0\)\
\-\ where\\:\\ 0\\.012455865197060418\ \(0\)\
\-\ initially\\:\\ 0\\.012421358372375643\ \(0\)\
\-\ range\\:\\ 0\\.012286571486722617\ \(0\)\
\-\ shown\\:\\ 0\\.012237309621964275\ \(0\)\
\-\ \\:\\:\\ 0\\.012110087314185697\ \(0\)\
\-\ currently\\:\\ 0\\.012093474267900204\ \(0\)\
\-\ complications\\:\\ 0\\.012093474267900204\ \(0\)\
\-\ use\\:\\ 0\\.012062282553726081\ \(0\)\
\-\ \\<\\:\\ 0\\.011778805455363537\ \(0\)\
\-\ skin\\:\\ 0\\.01172188905442492\ \(0\)\
\-\ defect\\:\\ 0\\.011424097593928309\ \(0\)\
\-\ signs\\:\\ 0\\.01074062833566448\ \(0\)\
\-\ given\\:\\ 0\\.010462194258986937\ \(0\)\
\-\ areas\\:\\ 0\\.010269097040164524\ \(0\)\
\-\ cases\\:\\ 0\\.010167181657075473\ \(0\)\
\-\ \\>\\:\\ 0\\.010139883980959158\ \(0\)\
\-\ space\\:\\ 0\\.010094846453845124\ \(0\)\
\-\ showed\\:\\ 0\\.01000644024258463\ \(0\)\
\-\ several\\:\\ 0\\.00981104584186567\ \(0\)\
\-\ day\\:\\ 0\\.009689142247689034\ \(0\)\
\-\ area\\:\\ 0\\.009649415157622382\ \(0\)\
\-\ abscess\\:\\ 0\\.009649415157622382\ \(0\)\
\-\ age\\:\\ 0\\.009288965448372523\ \(0\)\
\-\ to\\:\\ 0\\.00915145946663542\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.009121524070162342\ \(0\)\
\-\ from\\:\\ 0\\.009045969379672945\ \(0\)\
\-\ abdomen\\:\\ 0\\.009040658081770344\ \(0\)\
\-\ s\\:\\ 0\\.008752741668266383\ \(0\)\
\-\ include\\:\\ 0\\.008561262457251024\ \(0\)\
\-\ been\\:\\ 0\\.008302838890942825\ \(0\)\
\-\ significant\\:\\ 0\\.008206596968050798\ \(0\)\
\-\ therapy\\:\\ 0\\.008159431415145047\ \(0\)\
\-\ anterior\\:\\ 0\\.007859974370581205\ \(0\)\
\-\ increased\\:\\ 0\\.007466017077855913\ \(0\)\
\-\ soft\\:\\ 0\\.007431881299976964\ \(0\)\
\-\ posterior\\:\\ 0\\.007034423388223031\ \(0\)\
\-\ present\\:\\ 0\\.00689288840689886\ \(0\)\
\-\ contrast\\:\\ 0\\.006831341738599662\ \(0\)\
\-\ had\\:\\ 0\\.006585177925859672\ \(0\)\
\-\ 2\\:\\ 0\\.006571801773251951\ \(0\)\
\-\ female\\:\\ 0\\.0062741438265994055\ \(0\)\
\-\ no\\:\\ 0\\.0061460296478843\ \(0\)\
\-\ seen\\:\\ 0\\.006030812910956036\ \(0\)\
\-\ in\\:\\ 0\\.00601996043057507\ \(0\)\
\-\ within\\:\\ 0\\.005821897887093148\ \(0\)\
\-\ has\\:\\ 0\\.005731071323193849\ \(0\)\
\-\ that\\:\\ 0\\.00527135974485294\ \(0\)\
\-\ for\\:\\ 0\\.005207915347447965\ \(0\)\
\-\ disease\\:\\ 0\\.004988348361484657\ \(0\)\
\-\ normal\\:\\ 0\\.004784330194996789\ \(0\)\
\-\ the\\:\\ 0\\.004443727008330829\ \(0\)\
\-\ not\\:\\ 0\\.004410066684792626\ \(0\)\
\-\ ct\\:\\ 0\\.004268941619257296\ \(0\)\
\-\ an\\:\\ 0\\.004220231658159749\ \(0\)\
\-\ at\\:\\ 0\\.004134868402970118\ \(0\)\
\-\ or\\:\\ 0\\.0035768669605846697\ \(0\)\
\-\ was\\:\\ 0\\.0035295625793345955\ \(0\)\
\-\ of\\:\\ 0\\.0033286800227996694\ \(0\)\
\-\ patient\\:\\ 0\\.003059256896129957\ \(0\)\
\-\ a\\:\\ 0\\.002832855727275723\ \(0\)\
\-\ \\(\\:\\ 0\\.0025798633080137876\ \(0\)\
\-\ and\\:\\ 0\\.002571557224745978\ \(0\)\
\-\ \\)\\:\\ 0\\.0025483489004046607\ \(0\)\
\-\ is\\:\\ 0\\.00200818135137402\ \(0\)\
\-\ \\.\\:\\ 0\\.0010142724599241793\ \(0\)\
\-\ with\\:\\ 0\\.0008357441149277838\ \(0\)\
